Vivek K. Pawar
- Pharmaceutical Science top 0.5%
- Biomaterials top 5%
- Molecular Biology
- Biomedical Engineering
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Manish K. ChourasiaYuvraj SinghJaya Gopal MeherRajendra AwasthiShalini AsthanaMohini ChaurasiaAnuradha DubeGiriraj T. Kulkarni
- Topics
- Advanced Drug Delivery Systems (13 papers)Nanoparticle-Based Drug Delivery (12 papers)Drug Solubulity and Delivery Systems (10 papers)
- Journals
- Journal of Controlled ReleaseAntimicrobial Agents and ChemotherapyInternational Journal of Pharmaceutics
- Partner nations
- IndiaNew ZealandCzechia
In The Last Decade
Vivek K. Pawar
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Pharmaceutical Science 556
- Biomaterials 376
- Molecular Biology 339
- Biomedical Engineering 240
- Public Health, Environmental and Occupational Health 211
Countries citing papers authored by Vivek K. Pawar
This map shows the geographic impact of Vivek K. Pawar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek K. Pawar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek K. Pawar more than expected).
Fields of papers citing papers by Vivek K. Pawar
This network shows the impact of papers produced by Vivek K. Pawar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek K. Pawar. The network helps show where Vivek K. Pawar may publish in the future.
Co-authorship network of co-authors of Vivek K. Pawar
This figure shows the co-authorship network connecting the top 25 collaborators of Vivek K. Pawar. A scholar is included among the top collaborators of Vivek K. Pawar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek K. Pawar. Vivek K. Pawar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 16 | |
| 3 | 55 | |
| 4 | 15 | |
| 5 | 17 | |
| 6 | 6 | |
| 7 | 5 | |
| 8 | 29 | |
| 9 | 29 | |
| 10 | 83 | |
| 11 | 9 | |
| 12 | 69 | |
| 13 | 37 | |
| 14 | 16 | |
| 15 | 195 | |
| 16 | 60 | |
| 17 | 31 | |
| 18 | In - Vivo Assessment of Enhanced Bioavailability of Metronidazole with Piperine in Rabbits | 17 |
| 19 | Taste masking of Promethazine Hydrochloride using Eudragit E100via solid dispersion technique to develop fast disintegrating tablets | 3 |
| 20 | 149 |
About Vivek K. Pawar
Vivek K. Pawar is a scholar working on Pharmaceutical Science, Biomaterials and Small Animals, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (13 papers), Nanoparticle-Based Drug Delivery (12 papers) and Drug Solubulity and Delivery Systems (10 papers). The work is most often cited by research in Pharmaceutical Science (556 citations), Biomaterials (376 citations) and Molecular Medicine (79 citations). Vivek K. Pawar has collaborated with scholars based in India, New Zealand and Czechia. Frequent co-authors include Manish K. Chourasia, Yuvraj Singh, Jaya Gopal Meher, Rajendra Awasthi, Shalini Asthana, Mohini Chaurasia, Anuradha Dube, Giriraj T. Kulkarni, Siddharth Gupta and Anil K. Jaiswal. Their work appears in journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.